Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial
書誌事項
- 公開日
- 2015-12
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- DOI
-
- 10.1016/s1473-3099(15)00227-3
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- The Lancet Infectious Diseases
-
The Lancet Infectious Diseases 15 (12), 1389-1397, 2015-12
Elsevier BV